These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Untreated Graves' disease patients without clinical ophthalmopathy demonstrate a high frequency of extraocular muscle (EOM) enlargement by magnetic resonance. Villadolid MC; Yokoyama N; Izumi M; Nishikawa T; Kimura H; Ashizawa K; Kiriyama T; Uetani M; Nagataki S J Clin Endocrinol Metab; 1995 Sep; 80(9):2830-3. PubMed ID: 7673432 [TBL] [Abstract][Full Text] [Related]
11. [The course of the disease in endocrine orbitopathy. Magnetic resonance tomographic documentation]. Hosten N; Schörner W; Lietz A; Wenzel KW Rofo; 1992 Sep; 157(3):210-4. PubMed ID: 1391813 [TBL] [Abstract][Full Text] [Related]
12. Ultrasonic B-scan measurement of the extra-ocular muscles in Graves' orbitopathy. Willinsky RA; Arenson AM; Hurwitz JJ; Szalai J J Can Assoc Radiol; 1984 Jun; 35(2):171-3. PubMed ID: 6384227 [TBL] [Abstract][Full Text] [Related]
13. The use of real-time orbital ultrasound in Graves' ophthalmopathy: a comparison with computed tomography. Given-Wilson R; Pope RM; Michell MJ; Cannon R; McGregor AM Br J Radiol; 1989 Aug; 62(740):705-9. PubMed ID: 2670033 [TBL] [Abstract][Full Text] [Related]
14. Orbital lymphoma mimicking ophthalmopathy in a patient with Graves'. Moura Neto A; Denardi FC; Delamain MT; Tambascia MA; Vassallo J; Caldato R; Zantut-Wittmann DE Am J Med Sci; 2012 Nov; 344(5):418-21. PubMed ID: 22885624 [TBL] [Abstract][Full Text] [Related]
15. Can contrast enhanced MRI predict the response of Graves' ophthalmopathy to orbital radiotherapy? Ott M; Breiter N; Albrecht CF; Pradier O; Hess CF; Schmidberger H Br J Radiol; 2002 Jun; 75(894):514-7. PubMed ID: 12124238 [TBL] [Abstract][Full Text] [Related]
16. Thyroid eye disease: review and case reports. McGarvey EJ J Am Optom Assoc; 1990 Sep; 61(9):689-700. PubMed ID: 2212462 [TBL] [Abstract][Full Text] [Related]
18. Orbital gallium-67 scintigraphy in Graves' ophthalmopathy: a disease activity parameter that predicts the therapeutic response to immunosuppressive treatment. Konuk O; Atasever T; Unal M; Ayvaz G; Yetkin I; Cakir N; Arslan M; Hasanreisoglu B Thyroid; 2005 Apr; 15(4):358-63. PubMed ID: 15876160 [TBL] [Abstract][Full Text] [Related]
19. Quantitative CT of the orbit in Graves' disease. Ozgen A; Alp MN; Ariyürek M; Tütüncü NB; Can I; Günalp I Br J Radiol; 1999 Aug; 72(860):757-62. PubMed ID: 10624341 [TBL] [Abstract][Full Text] [Related]
20. Orbital scintigraphy with [111In-diethylenetriamine pentaacetic acid-D-phe1]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy. Colao A; Lastoria S; Ferone D; Pivonello R; Macchia PE; Vassallo P; Bonavolonta G; Muto P; Lombardi G; Fenzi G J Clin Endocrinol Metab; 1998 Nov; 83(11):3790-4. PubMed ID: 9814448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]